Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2016-05-24 19:06:53
Reporting Period:
Filing Date:
Accepted Time:
2016-05-24 19:06:53
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1340652 Chemocentryx Inc. CCXI () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1324991 L James Tyree C/o Chemocentryx, Inc.
850 Maude Avenue
Mountain View CA 94043
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-21 11,795 $0.00 26,119 No 4 M Direct
Common Stock Disposition 2016-05-23 5,544 $4.39 20,575 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2016-05-21 11,795 $0.00 11,795 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
  1. Shares were acquired upon vesting of restricted stock units awarded on May 21, 2015.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to cover estimated taxes due upon vesting of restricted stock units.
  3. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $4.25 to $4.59 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  4. Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
  5. 100% of the restricted stock units vested on May 21, 2016. Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.